Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning
ACT I
1 other identifier
observational
54
1 country
1
Brief Summary
The Inova research team will ask people who have had an experience of breast cancer and related changes to their cognition to complete some scales that researchers have established describe brain fog (called patient reported outcomes) and compare those results to the TOSL results. This will be done twice to see if changes are detected similarly on both types of measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 11, 2022
CompletedFirst Posted
Study publicly available on registry
August 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2024
CompletedMarch 7, 2025
March 1, 2025
1.9 years
August 11, 2022
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of months to recruit
Number of months between opening of recruitment and recruitment date of the 10th subject.
4 months
Correlation between the TOSL score and PAOFI score
Spearman correlation coefficient between the TOSL Lessons score and the PAOFI higher level cognition subscale score.
6 months
Eligibility Criteria
Men or women with stage I-III breast cancer.
You may qualify if:
- years of age or older
- ECOG performance status ≤ 2
- Patients diagnosed or with a history of breast cancer within the last 5 years.
- Life expectancy of at least 3 months
- Subject reports experiencing brain fog or cognitive impairment that the subject attributes to cancer or cancer therapy
- Able to sit for one hour and attend and respond to verbal and written instructions.
- Able to use a computer
You may not qualify if:
- Brain metastases from breast cancer
- Severe hearing or visual impairment
- Unable to give informed consent
- Unable to read and write in English
- Those diagnosed with history of neurologic injuries or disorders (e.g. seizures, strokes, traumatic brain injury, brain surgery, neurodegenerative disorders) other than those attributable to cancer or cancer therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inova Health Care Serviceslead
- The University of Texas at Dallascollaborator
Study Sites (1)
Inova HCS
Falls Church, Virginia, 22042, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam Cohen, MD
Inova Health Care Services
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2022
First Posted
August 29, 2022
Study Start
August 1, 2022
Primary Completion
June 18, 2024
Study Completion
October 18, 2024
Last Updated
March 7, 2025
Record last verified: 2025-03